197 related articles for article (PubMed ID: 11445254)
1. Decreased brain levels of 2',3'-cyclic nucleotide-3'-phosphodiesterase in Down syndrome and Alzheimer's disease.
Vlkolinský R; Cairns N; Fountoulakis M; Lubec G
Neurobiol Aging; 2001; 22(4):547-53. PubMed ID: 11445254
[TBL] [Abstract][Full Text] [Related]
2. 2',3'-cyclic nucleotide-3'-phosphodiesterase activity as an index of myelin in the post-mortem brains of patients with Alzheimer's disease.
Reinikainen KJ; Pitkänen A; Riekkinen PJ
Neurosci Lett; 1989 Nov; 106(1-2):229-32. PubMed ID: 2555748
[TBL] [Abstract][Full Text] [Related]
3. Changes of voltage-dependent anion-selective channel proteins VDAC1 and VDAC2 brain levels in patients with Alzheimer's disease and Down syndrome.
Yoo BC; Fountoulakis M; Cairns N; Lubec G
Electrophoresis; 2001 Jan; 22(1):172-9. PubMed ID: 11197169
[TBL] [Abstract][Full Text] [Related]
4. Synaptosomal proteins, beta-soluble N-ethylmaleimide-sensitive factor attachment protein (beta-SNAP), gamma-SNAP and synaptotagmin I in brain of patients with Down syndrome and Alzheimer's disease.
Yoo BC; Cairns N; Fountoulakis M; Lubec G
Dement Geriatr Cogn Disord; 2001; 12(3):219-25. PubMed ID: 11244216
[TBL] [Abstract][Full Text] [Related]
5. Decreased protein levels of stathmin in adult brains with Down syndrome and Alzheimer's disease.
Cheon MS; Fountoulakis M; Cairns NJ; Dierssen M; Herkner K; Lubec G
J Neural Transm Suppl; 2001; (61):281-8. PubMed ID: 11771751
[TBL] [Abstract][Full Text] [Related]
6. Decreased brain histamine-releasing factor protein in patients with Down syndrome and Alzheimer's disease.
Kim SH; Cairns N; Fountoulakisc M; Lubec G
Neurosci Lett; 2001 Mar; 300(1):41-4. PubMed ID: 11172935
[TBL] [Abstract][Full Text] [Related]
7. The reduction of NADH ubiquinone oxidoreductase 24- and 75-kDa subunits in brains of patients with Down syndrome and Alzheimer's disease.
Kim SH; Vlkolinsky R; Cairns N; Fountoulakis M; Lubec G
Life Sci; 2001 May; 68(24):2741-50. PubMed ID: 11400916
[TBL] [Abstract][Full Text] [Related]
8. Serotonin (5-HT) in brains of adult patients with Down syndrome.
Seidl R; Kaehler ST; Prast H; Singewald N; Cairns N; Gratzer M; Lubec G
J Neural Transm Suppl; 1999; 57():221-32. PubMed ID: 10666678
[TBL] [Abstract][Full Text] [Related]
9. Human brain nucleoside diphosphate kinase activity is decreased in Alzheimer's disease and Down syndrome.
Kim SH; Fountoulakis M; Cairns NJ; Lubec G
Biochem Biophys Res Commun; 2002 Aug; 296(4):970-5. PubMed ID: 12200143
[TBL] [Abstract][Full Text] [Related]
10. Increased levels of carbonic anhydrase II in the developing Down syndrome brain.
Palminiello S; Kida E; Kaur K; Walus M; Wisniewski KE; Wierzba-Bobrowicz T; Rabe A; Albertini G; Golabek AA
Brain Res; 2008 Jan; 1190():193-205. PubMed ID: 18083150
[TBL] [Abstract][Full Text] [Related]
11. Carbonic anhydrase and 2',3' cyclic nucleotide 3'-phosphohydrolase activity in normal human brain and in demyelinating diseases.
Lees MB; Sapirstein VS; Reiss DS; Kolodny EH
Neurology; 1980 Jul; 30(7 Pt 1):719-25. PubMed ID: 6248817
[TBL] [Abstract][Full Text] [Related]
12. Heart type fatty acid binding protein (H-FABP) is decreased in brains of patients with Down syndrome and Alzheimer's disease.
Cheon MS; Kim SH; Fountoulakis M; Lubec G
J Neural Transm Suppl; 2003; (67):225-34. PubMed ID: 15068254
[TBL] [Abstract][Full Text] [Related]
13. Protein levels of human peroxiredoxin subtypes in brains of patients with Alzheimer's disease and Down syndrome.
Kim SH; Fountoulakis M; Cairns N; Lubec G
J Neural Transm Suppl; 2001; (61):223-35. PubMed ID: 11771746
[TBL] [Abstract][Full Text] [Related]
14. Decreased levels of synaptosomal associated protein 25 in the brain of patients with Down syndrome and Alzheimer's disease.
Greber S; Lubec G; Cairns N; Fountoulakis M
Electrophoresis; 1999; 20(4-5):928-34. PubMed ID: 10344268
[TBL] [Abstract][Full Text] [Related]
15. Hexachlorophene and cuprizone induce the spongy change of the developing rat brain by different mechanisms: the role of 2', 3'-cyclic nucleotide 3'-phosphodiesterase (CNPase).
Kanno T; Sasaki S; Yamada N; Kawasako K; Tsuchitani M
J Vet Med Sci; 2012 Jul; 74(7):837-43. PubMed ID: 22313968
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of molecular chaperones in brain of patients with Down syndrome.
Yoo BC; Vlkolinsky R; Engidawork E; Cairns N; Fountoulakis M; Lubec G
Electrophoresis; 2001 Apr; 22(6):1233-41. PubMed ID: 11358150
[TBL] [Abstract][Full Text] [Related]
17. Expression of 2',3'-cyclic nucleotide 3'-phosphodiesterase (CNPase) in the developing olfactory bulb and subventricular zone rostral extension.
Gomes SS; Carvalho SL; Santiago MF; Lopez LB; Barradas PC; Cavalcante LA
J Neurosci Res; 2003 Aug; 73(4):471-80. PubMed ID: 12898532
[TBL] [Abstract][Full Text] [Related]
18. Comparison of immunocytochemical staining of astrocytes, oligodendrocytes, and myelinated fibers in the brains of carbonic anhydrase II-deficient mice and normal littermates.
Cammer W; Zhang H
J Neuroimmunol; 1991 Oct; 34(1):81-6. PubMed ID: 1716643
[TBL] [Abstract][Full Text] [Related]
19. 2'3'Cyclic nucleotide 3'phosphodiesterase immunohistochemistry shows an impairment on myelin compaction in hypothyroid rats.
Barradas PC; Ferraz AS; Ferreira AA; Daumas RP; Moura EG
Int J Dev Neurosci; 2000 Dec; 18(8):887-92. PubMed ID: 11154857
[TBL] [Abstract][Full Text] [Related]
20. Increased brain protein levels of carbonyl reductase and alcohol dehydrogenase in Down syndrome and Alzheimer's disease.
Balcz B; Kirchner L; Cairns N; Fountoulakis M; Lubec G
J Neural Transm Suppl; 2001; (61):193-201. PubMed ID: 11771743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
